Remote Patient Monitoring in Saudi Arabia: A Practical Guide for Diabetes and Hypertension Care
What the evidence says about remote monitoring for diabetes and hypertension, and how Saudi providers can start.
Key takeaways
- In the Saudi Health Interview Survey, 13.4% of Saudis aged 15 and older had diabetes, with 57.8% of those cases undiagnosed.
- Evidence shows telemonitoring combined with clinician teleconsultations reduced systolic blood pressure by around 5.6 mmHg at 6 and 12 months.
- Remote patient monitoring requires human clinical follow-up, as distributing devices alone does not reduce adverse outcomes like hospital readmissions.
Reviewed by the CareSync Medical Team · Last reviewed
On this page
Remote patient monitoring (RPM) collects health readings such as blood pressure and glucose from patients at home and sends them to a care team that can review trends and act early. In Saudi Arabia, where diabetes and hypertension are common and often undiagnosed or uncontrolled, RPM is one of the most practical ways to extend care between visits. The evidence is encouraging but specific: it works best when readings are paired with clinician contact, not when devices are simply handed out.
Key takeaways
- The burden is large and under-detected. In the Saudi Health Interview Survey, 13.4% of Saudis aged 15 and over had diabetes, and 57.8% of them were undiagnosed.
57.8%
Undiagnosed
Source: Saudi Health Interview Survey — 13.4% prevalence among Saudis aged 15+.
- Awareness is the gap in hypertension. A national survey found that among adults with hypertension, only 34.8% were aware of their condition.
- Aware of their condition34.8%
- Unaware65.2%
Source: KSA World Health Survey 2019.
- Telemonitoring plus clinician contact works best. A 2025 meta-analysis found telemonitoring combined with teleconsultations lowered systolic blood pressure by about 5.6 mmHg at both 6 and 12 months.
- Gains are modest and uneven. Reviews report HbA1c improvements of roughly 0.3 to 0.6 percentage points and mixed effects on blood pressure in diabetes.
- Devices alone are not enough. In heart failure, telemonitoring did not reduce readmission unless combined with human follow-up.
How big is the diabetes and hypertension challenge?
| Condition | Finding | Source |
|---|---|---|
| Diabetes | 13.4% prevalence among Saudis aged 15+; 57.8% of cases undiagnosed | Saudi Health Interview Survey |
| Diabetes | 8.5% prevalence in a later household survey, rising to 49.2% in people 60+ | General Authority for Statistics 2017 analysis |
| Hypertension | 12.69% crude prevalence in adults; over 50% at age 80+; 34.8% aware | KSA World Health Survey 2019 |
Estimates differ by survey, age range and definition, so quote the source and year every time. What all of them share is the pattern: prevalence rises sharply with age and a large share of people are unaware or uncontrolled.
What does the evidence say about RPM?
| Question | What reviews found | Source |
|---|---|---|
| Does telemonitoring lower blood pressure? | Yes when combined with teleconsultations: systolic fell 5.63 mmHg at 6 months and 5.59 mmHg at 12 months | Chronic Illness 2025 meta-analysis |
| Is telemonitoring better than self-monitoring for diabetes? | Not necessarily: glucose self-monitoring was as effective as telemonitoring at 6 months | Same review |
| How large are the effects in resource-constrained settings? | Systolic −6.60 mmHg and HbA1c −0.62% in one regional meta-analysis, with low certainty for HbA1c | Latin America and Caribbean review |
| Do home telemonitoring platforms change blood pressure in type 2 diabetes? | Changes were statistically significant but judged clinically negligible | Diabetes meta-analysis of 20 RCTs |
For context, the 2025 review notes that a 10 mmHg drop in systolic pressure or a 0.5% drop in HbA1c is associated with up to a 20% reduction in major cardiovascular events.
The implication: RPM is a service, not a device. Results depend on who reviews the data, how quickly they respond and whether the patient stays engaged.
What does a good RPM pathway include?
| Component | What good looks like |
|---|---|
| Patient selection | Clear criteria by condition and risk, with consent |
| Devices and onboarding | Validated devices, a first-reading check and Arabic instructions |
| Reading schedule | A realistic frequency that patients can sustain |
| Thresholds and alerts | Clinician-approved ranges with defined escalation |
| Clinical review | A named team reviewing trends on a fixed rhythm, with teleconsultation |
| Patient engagement | Reminders, feedback on progress and easy contact |
| Data governance | PDPL consent, secure storage and integration with the clinical record |
A five-step plan for Saudi providers
- Start with one cohort. Choose a group such as people with uncontrolled hypertension or newly started insulin, where early signals change decisions.
- Decide who reviews and when. Assign review time before buying devices.
- Write thresholds and escalation with clinicians. Keep them simple and tested.
- Support the patient's routine. Reminders and a human check-in in the first weeks matter most.
- Measure outcomes and workload. Track control rates, contact volume and review time, then decide whether to expand.
How CareSync helps
CareSync is a white-label health-tech ecosystem built in Riyadh. CareSync Network and CareSync Clinic are designed to give providers a branded channel for reading submission, reminders, check-ins and escalation to the care team, in Arabic and English. CareSync provides digital infrastructure; clinical protocols, thresholds and decisions remain with the treating clinicians. We do not claim to manage disease clinically.
Frequently asked questions
What is remote patient monitoring? Collecting readings such as blood pressure or glucose at home and sharing them with a care team that reviews trends and responds.
Does RPM work for hypertension? Evidence supports it when telemonitoring is combined with clinician teleconsultation, with systolic reductions of around 5 to 6 mmHg in pooled analyses.
Does RPM work for diabetes? Reviews show modest HbA1c improvements, and glucose self-monitoring alone was as effective as telemonitoring at 6 months in one review, so design and follow-up matter.
Who should be enrolled first? Patients where early information changes decisions, such as uncontrolled hypertension, recent diagnosis or treatment changes.
Is RPM suitable for older adults? Often yes, with simple devices and caregiver involvement, which is common in Saudi families.
What are the main risks? Alert overload, missed escalation, poor device accuracy and data privacy gaps. Each needs a defined owner.
How is RPM data protected? Health data is sensitive under the PDPL, so consent, access control and secure hosting should be designed in.
Can RPM reduce hospital readmissions? Not by itself. Heart failure evidence shows telemonitoring needs to be paired with human follow-up and clinic or home contact.
How often should patients submit readings in an RPM programme? The treating clinicians should set the schedule by condition and risk. Start with a routine patients can sustain, since over-collecting readings creates alert fatigue without improving decisions.
Who decides the blood pressure or glucose thresholds that trigger an alert? The clinical team, not the platform. Thresholds should be documented, kept simple, tested on scenarios before launch and linked to a named responder and escalation route.
Can RPM work alongside home healthcare visits in Saudi Arabia? Yes. The Ministry of Health has run a publicly funded home healthcare programme since 2009, mainly for older patients with chronic conditions such as diabetes and hypertension. Remote readings can help teams decide who needs a visit sooner.
Which patients are not suitable for RPM? Patients who cannot or will not take readings even with support, those whose condition needs in-person assessment, and anyone who has not given consent. Clinicians make the final call.
Monitoring that leads to action
RPM succeeds when data turns into timely, human decisions. Saudi providers who start with one cohort, assign review time and keep patients engaged can extend care safely between visits.
Planning a monitoring pathway? Book a CareSync demo at CareSync.
About CareSync
Prepared by the CareSync Medical Team. This article is educational, not medical advice or a substitute for clinical, legal or regulatory review. Research findings are source-specific, not measured CareSync outcomes.
Sources
- Saudi Health Interview Survey. Status of the diabetes epidemic in the Kingdom of Saudi Arabia.
- National and regional prevalence rates of diabetes in Saudi Arabia.
- Prevalence and risk factors of hypertension in Saudi Arabia.
- Managing cardiovascular risk factors with telemedicine in primary care, Chronic Illness, 2025.
- Telemedicine for cardiometabolic disease control in Latin America and the Caribbean.
- Home telemonitoring of patients with type 2 diabetes.
- Feltner, C. et al. Transitional care interventions to prevent readmissions for persons with heart failure. Annals of Internal Medicine, 2014.